A.P. Pharma, Inc.

A.P. Pharma, Inc. (NASDAQ NM: APPA) is a specialty pharmaceutical company focused on the development and commercialization of innovative medical treatments utilizing its proprietary polymer-based drug delivery systems.
The Company's primary emphasis is on advancing its Biochronomer™ technology platform for site-specific and systemic drug delivery. Designed to release drugs over a period of hours, days, weeks or even months, Biochronomer systems can be fabricated into a wide range of forms, ranging from solid strands to free-flowing gels which erode away as they deliver the drug. The Company's lead product candidate, APF530, for the prevention of chemotherapy-induced nausea and vomiting is expected to enter a Phase 3 clinical trial in the second quarter of 2006. In addition, a variety of injectable and implantable applications are undergoing testing to address major unmet needs in pain management, inflammation, and DNA/RNAI applications.

Contact Details: 123 Saginaw Drive Redwood City California 94063 United States of America Tel: 650-366-2626 Fax: Email: jobs@appharma.com WWW: www.appharma.com/

Loading...

BioNews Results for A.P. Pharma, Inc.:
IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European	Pharma Live:  Oct 6 2008 1:40AM Matching: pharma inc
Bayers Xarelto Approved in Canada	Pharma Live:  Oct 6 2008 1:04AM Matching: pharma inc
Anika Therapeutics Announces Exclusive Canadian Distribution Agreement for ELEVESS(R) with Canderm Pharma Inc	SmartBrief:  Oct 5 2008 5:39AM Matching: pharma inc
3 Pharma ETFs for a Sickly Market	Seeking Alpha:  Oct 5 2008 10:34AM Matching: pharma inc
Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Thera	SmartBrief:  Oct 5 2008 3:38PM Matching: pharma inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more A.P. Pharma, Inc. news.

A.P. Pharma, Inc. Patents:
US Patent No.	Title
7220414	Degradable polyacetal polymers
7163694	Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them
7045589	Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them
6946145	Block copolymers based on poly(ortho esters) containing amine groups
6863782	Method of preparing di(ketene acetals)
→View more A.P. Pharma, Inc. patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 244 times since April 2007, the link to the organisation's website has been followed 41 times

Recent Search Terms used to find this page: APF530 PATENT | A P Pharma | .

Search for more companies in Redwood City

Search for more companies in California

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for A.P. Pharma, Inc.